Snap poll after debate reveals state of presidential race between Trump and Harris Here’s how much you can expect your Social ...

Akums Drugs and Pharmaceuticals has secured a patent for a room-temperature stable Oral Suspension of Hydroxyurea, helping ...

ROCKVILLE, Md. and SOUTH SAN FRANCISCO, Calif., Sept. 15, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, ...

There's new hope for people with sickle cell disease which affects mainly African Americans. It's gene therapy research at ...

Although advancements have been made in treatment, many sickle cell disease warriors still face difficulties accessing ...

MaxCyte, Inc., (MXCT, MXCT.L), a cell-engineering focused company, Monday announced that it has entered into a strategic platform ...

This past December, the U.S. Food and Drug Administration approved the first cell-based gene therapies for treating sickle ...

The researchers took what they said was a conservative approach when plugging variables such as one-time and future costs ...

A London hospital has started using a rare technique to treat children with sickle cell disease. At St George’s Hospital in ...

Drew Agahiu, 17, has sickle cell disease, the group of inherited disorders that affect hemoglobin, which is a protein in the ...

The Louisiana Department of Health data shows about 80 infants are born with the blood disorder each year in Louisiana. The ...

Kamau is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene integration to develop a new class of therapies with the aim to cure a wide range of serious ...